Balloon rupture and alcohol leakage into the left anterior descending coronary artery during percutaneous septal ablation for hypertrophic obstructive cardiomyopathy;Rotura de balón y extravasación de alcohol hacia la arteria descendente anterior durante la ablación septal en paciente con miocardiopatía hipertrófica obstructiva

Revista Espanola de Cardiologia

Volumn 58, Issue 7, 2005, Pages 872-874

  Antolinos Pérez, María J ^a   de la Morena Valenzuela, Gonzalo ^a   Gimeno Blanes, Juan R ^a   Cerdán Sánchez, María del C ^a   Hurtado Martínez, José A ^a   Chavarri, Mariano Valdés ^a  

^a HOSPITAL UNIVERSITARIO VIRGEN DE LA ARRIXACA   (Spain)

Author keywords

Ablation; Complications; Hypertrophic obstructive cardiomyopathy

Indexed keywords

ALCOHOL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CREATINE KINASE; FUROSEMIDE; VERAPAMIL;

ADULT; ANGINA PECTORIS; ARTICLE; ARTIFICIAL HEART PACEMAKER; ATRIOVENTRICULAR BLOCK; BALLOON CATHETER; CASE REPORT; CATHETER ABLATION; CLINICAL FEATURE; CLINICAL OBSERVATION; COMPLETE HEART BLOCK; ECHOCARDIOGRAPHY; HEART FUNCTION; HEART LEFT VENTRICLE; HUMAN; HYPERTROPHIC OBSTRUCTIVE CARDIOMYOPATHY; HYPOKINESIA; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MALE; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; SINUS RHYTHM;

EID: 23644444933     PISSN: 03008932     EISSN: None     Source Type: Journal    
DOI: 10.1157/13077240     Document Type: Article

References (14)

1. Robbins RC, Stinson EB, Daily PO. Long-term results of left ventricular myotomy and myectomy for obstructive hypertrofic cardiomyopathy. J Thorac Cardiovasc Surg. 1996;111:586-94.
2. Maron BJ, Nishimura RA, McKenna WJ, Rakowski H, Josephson ME, Kieval RS, et al. Assessment of permanent dual-chamber pacing as a treatment for drug-refractary symptomatic patients with obstructive hypertrophic cardiomyopathy. A randomized, double-blind, crossover study (M-PATHY). Circulation. 1999;99:2927-33.
3. Seggewis H, Faber L. Percutaneous septal ablation for hypertrophic cardiomyopathy and mid-ventricular obstruction. Eur J Echocardiogr. 2000;1:277-80.
4. Seggewiss H, Rigopoulos A. Ablación septal en la miocardiopatía hipertrófica: situación actual. Rev Esp Cardiol. 2003;56:1153-9.
5. Candell Riera J, Aguadé Bruix S, Romero Farina G. Ablación septal en la miocardiopatía hipertrófica obstructiva. Rev Esp Cardiol. 2003;56:1231.
6. Seggewis H. Current status of alcohol septal ablation for patients with hypertrofic cardiomyopathy. Curr Cardiol Rep. 2001;3: 160-6.
7. Sigwart U. Non-surgical myocardial reduction of hypertrofic obstructive cardiomyopathy. Lancet. 1995;346:211-4.
8. Faber L, Meissner A, Ziemssen P, Seggewiss H. Percutaneus transluminal septal myocardial ablation for hypertrofic obstructive cardiomyopathy; long term follow up of the first series of 25 patients. Heart. 2000;83:326-31.
9. Gietzen FH, Leuner CJ, Raute-Kreinsen U, Dellmann A, Hegselmann J, Strunk-Mueller C, et al. Acute and long-term results after transcoronary ablation of septal hypertrofic (TASH). Catheter interventional treatment for hypertrofic obstructive cardiomyopathy. Eur Heart J. 1999;20:1342-54.
10. Kern MJ, Holmes DG, Simpson C, Bitar SR, Rajoub H. Delayed occurrence of complete heart block without warning after alcohol septal ablation for hypertrofic obstructive cardiomyopathy. Cathet Cardiovasc Interv. 2002;56:503-7.
11. Zhang W, Li Z, Zhang M, Yuan L, Guan R, Hou A, et al. Complications of percutaneous transluminal septal myocardial ablation in hypertrofic obstructive cardiomyopathy. Chin Med J. 2002;115:1283-6.
12. Faber L, Seggewiss H, Fassbender D, Ziemssen P, Schmidt HK, Gleichmann, et al. Guiding of percutaneous transluminal septal myocardial ablation in hypertrofic obstructive myocardiopathy by myocardial contrast echocardiography. Circulation. 1998;98: 2415-21.
13. Qin JX, Shiota T, Lever HM, Asher CR, Popovic ZB, Greenberg NL, et al. Conduction system abnormalities in patients with obstructive hypertrophic cardiomyopathy following septal reduction interventions. Am J Cardiol. 2004;93:171-5.
14. Knight C, Kurbaan AS, Seggewiss H, Henein M, Gunning M, Harrington D, et al. Nonsurgical septal reduction for hypertrophic obstructive cardiomyopathy. Circulation. 1997;95:2075-81.